Review



panc 1 human pancreatic ductal carcinoma cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC panc 1 human pancreatic ductal carcinoma cells
    Panc 1 Human Pancreatic Ductal Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8072 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/PANC-1/pm42252974-37-10-19
    Average 99 stars, based on 8072 article reviews
    panc 1 human pancreatic ductal carcinoma cells - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    other:

    Article Title: Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint.
    Article Snippet: 786-O renal cell adenocarcinoma (ATCC, CRL-1932), HT-29 colon adenocarcinoma (ATCC, HTB-38), PANC-1 pancreatic ductal carcinoma (ATCC, CRL-1469), HCT116 colorectal carcinoma (ATCC CCL-247), NCI-H1650 bronchoalveolar adenocarcinoma (ATCC CRL-5883), SCaBER urinary bladder squamous cell carcinoma (ATCC HTB-3), NK-92MI NK cell line (ATCC CRL-2408) and K-562 chronic myelogenous leukemia (ATCC, CRL-243) cell lines were purchased from ATCC.


    Article Title: Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint.
    Article Snippet: The Jurkat T-lymphoblast cell line used to generate the human NKG2A/CD94 CAR reporter cell line was purchased from DSMZ (DSMZ, ACC 282); the line used to generate the mouse NKG2A/CD94 CAR reporter cell line was purchased from ATCC (ATCC, TIB-152).

    Activity Assay:

    Article Title: A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers
    Article Snippet: .. Mango leaf extract at 200 μg/mL showed a cytotoxicity activity against human cancer cell lines; ductal carcinoma (BT474, ATCC HTB20), bronchogenic carcinoma (Chago K-1, ATCC HTB-168TB), liver hepatoblastoma (Hep-G2, ATCC HB8065), gastric carcinoma (Kato-III, ATCC HTB103), and colon adenocarcinoma (SW 620, ATCC CCL227) with IC 50 values > 200 μg/mL, even though mangiferin does not have any toxicity activity against all the cancer cell lines mentioned above [ , , ]. ..

    Article Title: A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers.
    Article Snippet: .. Mango leaf extract at 200 μg/mL showed a cytotoxicity activity against human cancer cell lines; ductal carcinoma (BT474, ATCC HTB20), bronchogenic carcinoma (Chago K-1, ATCC HTB-168TB), liver hepatoblastoma (Hep-G2, ATCC HB8065), gastric carcinoma (Kato-III, ATCC HTB103), and colon adenocarcinoma (SW 620, ATCC CCL227) with IC50 values > 200 μg/mL, even though mangiferin does not have any toxicity activity against all the cancer cell lines mentioned above [58,209,210]. ..

    Cell Culture:

    Article Title: Robust formation of optimal single spheroids towards cost-effective in vitro three-dimensional tumor models.
    Article Snippet: .. The human breast cancer BT-549 is ductal carcinoma (American Type Culture Collection ATCC) was cultured in Corning RPMI 1640 Medium with L-Glutamine (CorningTM RPMI 1640 Medium, Corning, NY, USA), 10% fetal calf serum and 0.023 U mL 1 insulin. .. The murine breast adenocarcinoma Py230 (American Type Culture Collection ATCC) was cultured in Corning Medium F-12K with L-glutamine (BioWhittaker Medium F12K Medium, Lonza), and 10% fetal calf serum, 0.1% MITO+ serum extender (Corning ).

    Article Title: Swift Formation Of Optimal Single Spheroids Towards In-Vitro 3-Dimensional Tumour Models
    Article Snippet: .. The human breast cancer BT-549 are ductal carcinoma (American Type Culture Collection ATCC, Virginia, USA) were cultured in Corning RPMI 1640 Medium with L-Glutamine (CorningTM RPMI 1640 Medium, New York, USA), 10% fetal calf serum and 0.023U/mL insulin. .. The murine breast adenocarcinoma Py230 (American Type Culture Collection ATCC, Virginia, USA) was cultured in Corning Medium F-12K with L-glutamine (BioWhittaker® Medium F12K Medium, Lonza, Maryland, USA), and 10% fetal calf serum, 0.1% MITO + serum extender (Corning®, New York, USA) .

    Article Title: Robust formation of optimal single spheroids towards cost‐effective in vitro three‐dimensional tumor models
    Article Snippet: .. The human breast cancer BT‐549 is ductal carcinoma (American Type Culture Collection ATCC) was cultured in Corning RPMI 1640 Medium with L‐Glutamine (CorningTM RPMI 1640 Medium, Corning, NY, USA), 10% fetal calf serum and 0.023 U·mL −1 insulin. .. The murine breast adenocarcinoma Py230 (American Type Culture Collection ATCC) was cultured in Corning Medium F‐12K with L‐glutamine (BioWhittaker ® Medium F12K Medium, Lonza), and 10% fetal calf serum, 0.1% MITO+ serum extender (Corning ® ).



    Similar Products

    99
    ATCC panc 1 human pancreatic ductal carcinoma cells
    Panc 1 Human Pancreatic Ductal Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/PANC-1/pm42252974-37-10-19
    Average 99 stars, based on 1 article reviews
    panc 1 human pancreatic ductal carcinoma cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC invasive ductal carcinoma mcf7 cells
    Invasive Ductal Carcinoma Mcf7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/MCF7/pm42270027-81-9-14
    Average 99 stars, based on 1 article reviews
    invasive ductal carcinoma mcf7 cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC panc 1 pancreatic ductal carcinoma cell line
    Panc 1 Pancreatic Ductal Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/PANC-1/pmc13253391-52-1-11
    Average 99 stars, based on 1 article reviews
    panc 1 pancreatic ductal carcinoma cell line - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    86
    10X Genomics visium invasive ductal carcinoma data
    Visium Invasive Ductal Carcinoma Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/high+in+platform+plex+situ/pmc13198003-299-0-8
    Average 86 stars, based on 1 article reviews
    visium invasive ductal carcinoma data - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    10X Genomics visium invasive ductal carcinoma stained with fluorescent cd3 antibody
    PHD-MS analyzes tumor microenvironment morphology (A) Expert annotated tumors from immunofluorescent image, with <t>anti-CD3</t> intensity in pink and DAPI intensity in green. IDC is outlined in yellow, carcinoma in situ is outlined in blue, benign hyperplasia is outlined in red, and unclassified tumor is in green. (B) Prominent multiscale domains identified by PHD-MS, selected from the most persistent domains. Regions are numbered to correspond with the labels in (A). (C) PHD-MS heterogeneity map highlights highly heterogeneous regions. The heterogeneity score approximates the number of persistent domains that contain each spot. (D) Mean normalized immune expression from a set of immune genes (PTPRC, CD4, CD8A, CD14, CD68, and IGHG3). (E) Normalized expression of key oncogenes APOE, PGK1, and MALAT1 in the lower IDC. From DGE analysis, APOE is overexpressed in region 7 relative to 8 and 9, PGK1 is overexpressed in 8, and MALAT1 is overexpressed in 9.
    Visium Invasive Ductal Carcinoma Stained With Fluorescent Cd3 Antibody, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/cell+single+suspension/pmc13198003-3-0-14
    Average 86 stars, based on 1 article reviews
    visium invasive ductal carcinoma stained with fluorescent cd3 antibody - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    hcc38  (ATCC)
    94
    ATCC hcc38
    PHD-MS analyzes tumor microenvironment morphology (A) Expert annotated tumors from immunofluorescent image, with <t>anti-CD3</t> intensity in pink and DAPI intensity in green. IDC is outlined in yellow, carcinoma in situ is outlined in blue, benign hyperplasia is outlined in red, and unclassified tumor is in green. (B) Prominent multiscale domains identified by PHD-MS, selected from the most persistent domains. Regions are numbered to correspond with the labels in (A). (C) PHD-MS heterogeneity map highlights highly heterogeneous regions. The heterogeneity score approximates the number of persistent domains that contain each spot. (D) Mean normalized immune expression from a set of immune genes (PTPRC, CD4, CD8A, CD14, CD68, and IGHG3). (E) Normalized expression of key oncogenes APOE, PGK1, and MALAT1 in the lower IDC. From DGE analysis, APOE is overexpressed in region 7 relative to 8 and 9, PGK1 is overexpressed in 8, and MALAT1 is overexpressed in 9.
    Hcc38, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/HCC38%3B+Breast+Ductal+Carcinoma%3B+Human/pm41811965-291-5-6
    Average 94 stars, based on 1 article reviews
    hcc38 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    10X Genomics invasive ductal carcinoma
    PHD-MS analyzes tumor microenvironment morphology (A) Expert annotated tumors from immunofluorescent image, with <t>anti-CD3</t> intensity in pink and DAPI intensity in green. IDC is outlined in yellow, carcinoma in situ is outlined in blue, benign hyperplasia is outlined in red, and unclassified tumor is in green. (B) Prominent multiscale domains identified by PHD-MS, selected from the most persistent domains. Regions are numbered to correspond with the labels in (A). (C) PHD-MS heterogeneity map highlights highly heterogeneous regions. The heterogeneity score approximates the number of persistent domains that contain each spot. (D) Mean normalized immune expression from a set of immune genes (PTPRC, CD4, CD8A, CD14, CD68, and IGHG3). (E) Normalized expression of key oncogenes APOE, PGK1, and MALAT1 in the lower IDC. From DGE analysis, APOE is overexpressed in region 7 relative to 8 and 9, PGK1 is overexpressed in 8, and MALAT1 is overexpressed in 9.
    Invasive Ductal Carcinoma, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/high+in+platform+plex+situ/pm41677098-385-29-33
    Average 86 stars, based on 1 article reviews
    invasive ductal carcinoma - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    ATCC human pancreatic ductal adeno carcinoma
    PHD-MS analyzes tumor microenvironment morphology (A) Expert annotated tumors from immunofluorescent image, with <t>anti-CD3</t> intensity in pink and DAPI intensity in green. IDC is outlined in yellow, carcinoma in situ is outlined in blue, benign hyperplasia is outlined in red, and unclassified tumor is in green. (B) Prominent multiscale domains identified by PHD-MS, selected from the most persistent domains. Regions are numbered to correspond with the labels in (A). (C) PHD-MS heterogeneity map highlights highly heterogeneous regions. The heterogeneity score approximates the number of persistent domains that contain each spot. (D) Mean normalized immune expression from a set of immune genes (PTPRC, CD4, CD8A, CD14, CD68, and IGHG3). (E) Normalized expression of key oncogenes APOE, PGK1, and MALAT1 in the lower IDC. From DGE analysis, APOE is overexpressed in region 7 relative to 8 and 9, PGK1 is overexpressed in 8, and MALAT1 is overexpressed in 9.
    Human Pancreatic Ductal Adeno Carcinoma, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/HPAC/bio_rxiv__64898__2026__01__28__701378-215-0-12
    Average 96 stars, based on 1 article reviews
    human pancreatic ductal adeno carcinoma - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    97
    ATCC ductal carcinoma hcc1937
    PHD-MS analyzes tumor microenvironment morphology (A) Expert annotated tumors from immunofluorescent image, with <t>anti-CD3</t> intensity in pink and DAPI intensity in green. IDC is outlined in yellow, carcinoma in situ is outlined in blue, benign hyperplasia is outlined in red, and unclassified tumor is in green. (B) Prominent multiscale domains identified by PHD-MS, selected from the most persistent domains. Regions are numbered to correspond with the labels in (A). (C) PHD-MS heterogeneity map highlights highly heterogeneous regions. The heterogeneity score approximates the number of persistent domains that contain each spot. (D) Mean normalized immune expression from a set of immune genes (PTPRC, CD4, CD8A, CD14, CD68, and IGHG3). (E) Normalized expression of key oncogenes APOE, PGK1, and MALAT1 in the lower IDC. From DGE analysis, APOE is overexpressed in region 7 relative to 8 and 9, PGK1 is overexpressed in 8, and MALAT1 is overexpressed in 9.
    Ductal Carcinoma Hcc1937, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/HCC1937/pm41422484-228-9-12
    Average 97 stars, based on 1 article reviews
    ductal carcinoma hcc1937 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    99
    ATCC ductal carcinoma mcf 7
    PHD-MS analyzes tumor microenvironment morphology (A) Expert annotated tumors from immunofluorescent image, with <t>anti-CD3</t> intensity in pink and DAPI intensity in green. IDC is outlined in yellow, carcinoma in situ is outlined in blue, benign hyperplasia is outlined in red, and unclassified tumor is in green. (B) Prominent multiscale domains identified by PHD-MS, selected from the most persistent domains. Regions are numbered to correspond with the labels in (A). (C) PHD-MS heterogeneity map highlights highly heterogeneous regions. The heterogeneity score approximates the number of persistent domains that contain each spot. (D) Mean normalized immune expression from a set of immune genes (PTPRC, CD4, CD8A, CD14, CD68, and IGHG3). (E) Normalized expression of key oncogenes APOE, PGK1, and MALAT1 in the lower IDC. From DGE analysis, APOE is overexpressed in region 7 relative to 8 and 9, PGK1 is overexpressed in 8, and MALAT1 is overexpressed in 9.
    Ductal Carcinoma Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ductal+carcinoma/MCF7/pmc12716403-233-8-18
    Average 99 stars, based on 1 article reviews
    ductal carcinoma mcf 7 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    PHD-MS analyzes tumor microenvironment morphology (A) Expert annotated tumors from immunofluorescent image, with anti-CD3 intensity in pink and DAPI intensity in green. IDC is outlined in yellow, carcinoma in situ is outlined in blue, benign hyperplasia is outlined in red, and unclassified tumor is in green. (B) Prominent multiscale domains identified by PHD-MS, selected from the most persistent domains. Regions are numbered to correspond with the labels in (A). (C) PHD-MS heterogeneity map highlights highly heterogeneous regions. The heterogeneity score approximates the number of persistent domains that contain each spot. (D) Mean normalized immune expression from a set of immune genes (PTPRC, CD4, CD8A, CD14, CD68, and IGHG3). (E) Normalized expression of key oncogenes APOE, PGK1, and MALAT1 in the lower IDC. From DGE analysis, APOE is overexpressed in region 7 relative to 8 and 9, PGK1 is overexpressed in 8, and MALAT1 is overexpressed in 9.

    Journal: Cell Reports Methods

    Article Title: Multiscale domain identification for spatial transcriptomics via persistent homology

    doi: 10.1016/j.crmeth.2026.101376

    Figure Lengend Snippet: PHD-MS analyzes tumor microenvironment morphology (A) Expert annotated tumors from immunofluorescent image, with anti-CD3 intensity in pink and DAPI intensity in green. IDC is outlined in yellow, carcinoma in situ is outlined in blue, benign hyperplasia is outlined in red, and unclassified tumor is in green. (B) Prominent multiscale domains identified by PHD-MS, selected from the most persistent domains. Regions are numbered to correspond with the labels in (A). (C) PHD-MS heterogeneity map highlights highly heterogeneous regions. The heterogeneity score approximates the number of persistent domains that contain each spot. (D) Mean normalized immune expression from a set of immune genes (PTPRC, CD4, CD8A, CD14, CD68, and IGHG3). (E) Normalized expression of key oncogenes APOE, PGK1, and MALAT1 in the lower IDC. From DGE analysis, APOE is overexpressed in region 7 relative to 8 and 9, PGK1 is overexpressed in 8, and MALAT1 is overexpressed in 9.

    Article Snippet: Visium Invasive Ductal Carcinoma Stained With Fluorescent CD3 Antibody , Zhao et al. , https://www.10xgenomics.com/datasets/invasive-ductal-carcinoma-stained-with-fluorescent-cd-3-antibody-1-standard-1-2-0.

    Techniques: In Situ, Expressing